Skip to main content

Peer Review reports

From: Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

Original Submission
17 Feb 2014 Submitted Original manuscript
10 Mar 2014 Reviewed Reviewer Report - Rajiv Tandon
16 Mar 2014 Reviewed Reviewer Report - P Blier
7 Apr 2014 Author responded Author comments - Brian Godman
Resubmission - Version 2
7 Apr 2014 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
7 Apr 2014 Author responded Author comments - Brian Godman
Resubmission - Version 4
7 Apr 2014 Submitted Manuscript version 4
17 May 2014 Author responded Author comments - Brian Godman
Resubmission - Version 5
17 May 2014 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
19 May 2014 Author responded Author comments - Brian Godman
Resubmission - Version 7
19 May 2014 Submitted Manuscript version 7
19 May 2014 Author responded Author comments - Brian Godman
Resubmission - Version 8
19 May 2014 Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
23 May 2014 Author responded Author comments - Brian Godman
Resubmission - Version 10
23 May 2014 Submitted Manuscript version 10
Publishing
23 May 2014 Editorially accepted
13 Jun 2014 Article published 10.1186/1741-7015-12-98

You can find further information about peer review here.

Back to article page